Cargando…
A case of advanced adenocarcinoma genetically confirmed with EGFR/BRAF co-mutation in both primary and metastatic lesions
Driver mutations in lung cancer have been generally considered mutually exclusive; however, multiple gene screenings have recently become mainstream. Therefore, it is not uncommon to identify two or more mutations at first diagnosis, making it difficult to determine which tyrosine kinase inhibitor t...
Autores principales: | Morikawa, Kei, Iinuma, Masahiro, Shinozaki, Yusuke, Nishine, Hiroki, Inoue, Takeo, Mineshita, Masamichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544759/ https://www.ncbi.nlm.nih.gov/pubmed/34707694 http://dx.doi.org/10.1177/17588359211053420 |
Ejemplares similares
-
Left and Right Lung Asynchrony as a Physiological Indicator for Unilateral Bronchial Obstruction in Interventional Bronchoscopy
por: Mineshita, Masamichi, et al.
Publicado: (2014) -
Drug-induced Hypersensitivity Syndrome by EGFR-TKI in a Patient with Lung Cancer
por: Oyama, Baku, et al.
Publicado: (2021) -
Evaluation of Droplet Countermeasures by a Particle Visualization System in Simulated Bronchoscopy
por: Morikawa, Kei, et al.
Publicado: (2021) -
Preliminary Results of NGS Gene Panel Test Using NSCLC Sputum Cytology and Therapeutic Effect Using Corresponding Molecular-Targeted Drugs
por: Morikawa, Kei, et al.
Publicado: (2022) -
A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer
por: Tsunoda, Akihito, et al.
Publicado: (2019)